Download
40635_2024_Article_617.pdf 1,59MB
WeightNameValue
1000 Titel
  • Isoflurane, like sepsis, decreases CYP1A2 liver enzyme activity in intensive care patients: a clinical study and network model
1000 Autor/in
  1. Köhler, Thomas |
  2. Schwier, Elke |
  3. Praxenthaler, Janina |
  4. Kirchner, Carmen |
  5. Winde, Günther |
  6. Koos, Björn |
  7. Henzler, Dietrich |
1000 Verlag
  • Springer International Publishing
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-04-08
1000 Erschienen in
1000 Quellenangabe
  • 12(1):33
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s40635-024-00617-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11001842/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Purpose</jats:title> <jats:p>Liver function of intensive care patients is routinely monitored by static blood pathology. For specific indications, liver specific cytochrome activity may be measured by the commercially available maximum liver function capacity (LiMAx) test via quantification of the cytochrome P450 1A2 (CYP1A2) dependent C-methacetin metabolism. Sedation with the volatile anesthetic isoflurane was suspected to abrogate the correlation of LiMAx test with global liver function. We hypothesized that isoflurane has a CYP1A2-activity and LiMAx test result decreasing effect.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>In this monocentric, observational clinical study previously liver healthy intensive care patients, scheduled to be changed from propofol to isoflurane sedation, were enrolled. LiMAx testing was done before, during and after termination of isoflurane sedation.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>The mean LiMAx value decreased during isoflurane sedation. Septic patients (<jats:italic>n</jats:italic> = 11) exhibited lower LiMAx values compared to non-septic patients (<jats:italic>n</jats:italic> = 11) at all time points. LiMAx values decreased with isoflurane from 140 ± 82 to 30 ± 34 µg kg<jats:sup>−1</jats:sup> h<jats:sup>−1</jats:sup> in the septic group and from 253 ± 92 to 147 ± 131 µg kg<jats:sup>−1</jats:sup> h<jats:sup>−1</jats:sup> in the non-septic group while laboratory markers did not imply significant hepatic impairment. Lactate increased during isoflurane inhalation without clinical consequence.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusion</jats:title> <jats:p>Sepsis and isoflurane have independently demonstrated an effect on reducing the hepatic CYP1A2-activity. A network model was constructed that could explain the mechanism through the influence of isoflurane on hypoxia inducible factor (HIF-1α) by upregulation of the hypoxia-inducible pathway and the downregulation of CYP1A2-activity via the ligand-inducible pathway. Thus, the increased anaerobic metabolism may result in lactate accumulation. The influence of isoflurane sedation on the validated correlation of global liver function with CYP1A2-activity measured by LiMAx testing needs to be investigated in more detail.</jats:p> </jats:sec>
1000 Sacherschließung
lokal Cytochrome P450 1A2
lokal LiMAx
lokal Isoflurane
lokal Maximum liver function capacity test
lokal Sepsis
lokal Hypoxia inducible factor
lokal Research Articles
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0003-0399-8382|https://orcid.org/0000-0002-9279-2986|https://orcid.org/0000-0002-8266-1800|https://orcid.org/0000-0003-2356-2877|https://orcid.org/0000-0001-9131-5275|https://orcid.org/0000-0002-0544-4124|https://orcid.org/0000-0001-5511-6885
1000 Hinweis
  • DeepGreen-ID: 27da53617e0b4c149ac2a85322c520dd ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Ruhr-Universität Bochum |
1000 Fördernummer
  1. -
1000 Förderprogramm
  1. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Ruhr-Universität Bochum |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6497556.rdf
1000 Erstellt am 2025-02-04T17:58:04.410+0100
1000 Erstellt von 322
1000 beschreibt frl:6497556
1000 Zuletzt bearbeitet 2025-07-30T12:14:19.963+0200
1000 Objekt bearb. Wed Jul 30 12:14:19 CEST 2025
1000 Vgl. frl:6497556
1000 Oai Id
  1. oai:frl.publisso.de:frl:6497556 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source